ctrl K

Price Alert

Arcturus Therapeutics In... (ARCT)

NASDAQ: ARCT · Real-Time Price · USD

17.93

-1.55 (-7.96%)

At close: Aug 18, 2025, 3:59 PM

17.91

-0.11%

Pre-market: Aug 19, 2025, 06:00 AM EDT

Arcturus Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	237.03M	292M	391.88M	370.49M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	1.89M	1.89M	2.09M	515K
Other Long-Term Assets	n/a	n/a	n/a	2.08M
Receivables	3.97M	32.06M	2.76M	3.37M
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	64.98M	55M	8.69M	n/a
Total Current Assets	305.98M	386.59M	403.33M	378.96M
Property-Plant & Equipment	36.2M	40.93M	44.96M	11.26M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	38.09M	42.81M	47.05M	13.85M
Total Assets	344.07M	429.4M	450.39M	392.81M
Account Payables	7.19M	5.28M	7.45M	10.06M
Deferred Revenue	21.93M	47.34M	36.12M	43.48M
Short-Term Debt	3.55M	n/a	60.66M	22.47M
Other Current Liabilities	3.89M	18.5M	n/a	18.41M
Total Current Liabilities	65.49M	81.99M	126.98M	99.54M
Long-Term Debt	n/a	n/a	n/a	40.63M
Other Long-Term Liabilities	n/a	497K	2.8M	19.93M
Total Long-Term Liabilities	37.6M	68.9M	53.09M	65.07M
Total Liabilities	103.09M	150.89M	180.07M	164.6M
Total Debt	28.55M	30.22M	94.75M	69.15M
Common Stock	27K	27K	27K	26K
Retained Earnings	-448.81M	-367.87M	-338.14M	-347.49M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	240.98M	278.51M	270.31M	228.21M
Total Investments	1.89M	1.89M	2.09M	515K